Literature DB >> 1864125

Inverse ratio ventilation in ARDS. Rationale and implementation.

T W Marcy1, J J Marini.   

Abstract

Conventional ventilatory support of patients with the adult respiratory distress syndrome (ARDS) consists of volume-cycled ventilation with applied positive end-expiratory pressure (PEEP). Unfortunately, recent evidence suggests that this strategy, as currently implemented, may perpetuate lung damage by overinflating and injuring distensible alveolar tissues. An alternative strategy--termed inverse ratio ventilation (IRV)--extends the inspiratory time, and, in concept, maintains or improves gas exchange at lower levels of PEEP and peak distending pressures. There are two methods to administer IRV: (1) volume-cycled ventilation with an end-inspiratory pause, or with a slow or decelerating inspiratory flow rate; or (2) pressure-controlled ventilation applied with a long inspiratory time. There are several real or theoretical problems common to both forms of IRV: excessive gas-trapping; adverse hemodynamic effects; and the need for sedation in most patients. Although there are many anecdotal reports of IRV, there are no controlled studies that compare outcome in ARDS patients treated with IRV as opposed to conventional ventilation. Nonetheless, clinicians are using IRV with increasing frequency. In the absence of well-designed clinical trials, we present interim guidelines for a ventilatory strategy in patients with ARDS based on the literature and our own clinical experience.

Entities:  

Mesh:

Year:  1991        PMID: 1864125     DOI: 10.1378/chest.100.2.494

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  18 in total

Review 1.  Ventilatory strategies and adjunctive therapy in ARDS.

Authors:  Ajay R Desai; Akash Deep
Journal:  Indian J Pediatr       Date:  2006-08       Impact factor: 1.967

Review 2.  New concepts in mechanical ventilation for ARDS.

Authors:  M R Lessard
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

3.  Physiological effects of reduced tidal volume at constant minute ventilation and inspiratory flow rate in acute respiratory distress syndrome.

Authors:  R Kiiski; S Kaitainen; R Karppi; J Takala
Journal:  Intensive Care Med       Date:  1996-03       Impact factor: 17.440

Review 4.  The American-European Consensus Conference on ARDS, part 2. Ventilatory, pharmacologic, supportive therapy, study design strategies and issues related to recovery and remodeling.

Authors:  A Artigas; G R Bernard; J Carlet; D Dreyfuss; L Gattinoni; L Hudson; M Lamy; J J Marini; M A Matthay; M R Pinsky; R Spragg; P M Suter
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

5.  Perioperative respiratory assessment and management.

Authors:  P D Slinger
Journal:  Can J Anaesth       Date:  1992-05       Impact factor: 5.063

Review 6.  Is ventilator-induced lung injury a promoter of multiple organ failure in adult respiratory distress syndrome? The effect of permissive hypercapnia on oxygenation and outcome.

Authors:  Keith G Hickling
Journal:  J Anesth       Date:  1997-03       Impact factor: 2.078

Review 7.  Consensus conference on mechanical ventilation--January 28-30, 1993 at Northbrook, Illinois, USA. Part 2.

Authors:  A S Slutsky
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

8.  Different ventilatory approaches to keep the lung open.

Authors:  U H Sjöstrand; M Lichtwarck-Aschoff; J B Nielsen; A Markström; A Larsson; B A Svensson; G A Wegenius; K A Nordgren
Journal:  Intensive Care Med       Date:  1995-04       Impact factor: 17.440

9.  Effect of prolonged inspiratory time on gas exchange during robot-assisted laparoscopic urologic surgery.

Authors:  M Hur; S-K Park; D E Jung; S Yoo; J-Y Choi; W H Kim; J T Kim; J-H Bahk
Journal:  Anaesthesist       Date:  2018-09-17       Impact factor: 1.041

Review 10.  High-inflation pressure and positive end-expiratory pressure. Injurious to the lung? Yes.

Authors:  P J Papadakos; M J Apostolakos
Journal:  Crit Care Clin       Date:  1996-07       Impact factor: 3.879

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.